Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael F. Maclean currently holds 65,806 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael F. Maclean has been a net seller of AKCA stock. They have purchased $0 and sold $10.6M worth of shares.
Michael F. Maclean's most recent insider trade was on Aug 6, 2025, when they sold 30,914 shares at $42.73 per share.
Michael F. Maclean serves as Executive at AKCEA THERAPEUTICS, INC. (AKCA). They have executed 71 insider transactions totaling $10.6M over their tenure at the company.
Michael F. Maclean holds the position of Executive at AKCEA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael F. Maclean has shown a selling trading pattern, with $0 in total purchases and $10.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael F. Maclean was on Jun 12, 2024, when they sold $3.7M worth of RNA shares. This transaction involved 104,245 shares at $35.72 per share.
Michael F. Maclean currently owns 65,806 shares of AKCEA THERAPEUTICS, INC. (AKCA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael F. Maclean's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael F. Maclean has 71 Form 4 filings on record as an insider at AKCEA THERAPEUTICS, INC..
Set alerts for Michael F. Maclean and 40,000+ other insiders.